| [1] |
Jajosky RP, Cook LO, Manaloor E，et al.Hematologic complications in a patient with glycinesoja polyagglutination following fresh frozen plasma transfusion[J]．Immunohematology，2017，33(2): 51-55.
|
| [2] |
Melland C, Hintz C．Detecting polyagglutinable red blood cells[J]．Immunohematology，2018，34(3): 113-117.
|
| [3] |
Chang CJ, Chiu NC, Huang FY，et al.Predictive value of Thomsen-Friedenreich antigen activation for Streptococcus pneumoniae infection and severity in pediatric lobar pneumonia[J]．J Microbiol Immunol Infect，2019，52(4): 571-577.
|
| [4] |
Karacosta LG, Fisk JC, Jessee J，et al.Preclinical analysis of JAA-F11，a specific anti-thomsen-friedenreich antibody via immunohistochemistry and in vivo imaging[J]．Transl Oncol，2018，11(2): 450-466.
|
| [5] |
Horn KD.The classification，recognition and significance of polyagglutination in transfusion medicine[J]．Blood Rev，1999，13(1): 36-44.
|
| [6] |
汪德清．输血技术操作规程(输血科部分)[M]．北京：人民卫生出版社，2016：13-63.
|
| [7] |
桂荣，张志昇，王勇军．输血相容性检测及疑难病例分析[M]．北京：人民卫生出版社，2018：314-316.
|
| [8] |
Judd WJ, Johnson ST, Storry JR.Judd′s methods in immunohematology[M]. 3th ed. Bethesda，MD：AABB Press, 2008：559-569.
|
| [9] |
朱碎永，朱燕英，林甲进．肠道疾病引起红细胞T活化的检查分析[J]．中国实验诊断学，2007，11(3): 296-297.
|
| [10] |
Ju T, Wang Y, Aryal RP，et al.Tn and sialyl-Tn antigens，aberrant O-glycomics as human disease markers[J]．Proteomics Clin Appl，2013，7(9/10): 618-631.
|
| [11] |
Ju T, Aryal RP, Kudelka MR，et al.The cosmc connection to the Tn antigen in cancer[J]．Cancer Biomark，2014，14(1): 63-81.
|
| [12] |
Rinaudo-Gaujous M, Talagrand E, Verhoeven PO，et al.A case report of Streptococcus pneumoniae-induced hemolytic uremic syndrome：appropriate transfusional management by T-antigen determination[J]．Ann Biol Clin (Paris)，2013，71(2): 215-218.
|
| [13] |
Burin des Roziers N, Chadebech P, Bodivit G，et al.Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia[J]．Transfusion，2015，55(6): 1563-1571.
|
| [14] |
Dinkla S, van Eijk LT, Fuchs B，et al.Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane[J]．BBA Clin，2016，3(5): 186-192.
|
| [15] |
Daniels G．Human Blood Groups[M].3th ed.NJ：Wiley-Blackwell，2013：515-523.
|
| [16] |
Sas SS.In-house preparation of lectin panel and detection of Tn polyagglutination[J]．Asian J Transfus Sci，2015，9(1): 102-103.
|
| [17] |
Gorakshakar AC, Ghosh K．Use of lectins in immunohematology[J]．Asian J Transfus Sci，2016，10(1): 12-21.
|
| [18] |
Williams RA, Brown EF, Hurst D，et al.Transfusion of infants with activation of erythrocyte T antigen[J]．J Pediatr，1989，115(6): 949-953.
|
| [19] |
Wenzel CQ, Mills DC, Dobruchowska JM, et al. An atypical lipoteichoic acid from Clostridium perfringens elicits a broadly cross-reactive and protective immune response[J]．J Biol Chem，2020，295(28): 9513-9530.
|
| [20] |
Moh-Klaren J, Bodivit G, Jugie M，et al.Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis，Clostridium perfringens infection，and red blood cell T-polyagglutination[J]．Transfusion，2017，57(11): 2571-2577.
|
| [21] |
Roseff SD.Cryptantigens: time to uncover the real significance of T-activation[J]．Transfusion，2017，57(11): 2553-2557.
|
| [22] |
Boralessa H, Modi N, Cockburn H, et al.RBC T activation andhemolysis in a neonatal intensive care population: implications for transfusion practice[J]．Transfusion，2002，42(11): 1428-1434.
|
| [23] |
Wang LY, Chan YS, Chang FC, et al. Thomsen-Friedenreich activation in infants with necrotizing enterocolitis in Taiwan[J]．Transfusion，2011，51(9): 1972-1976.
|
| [24] |
Stöllberger C, Krutisch G, Finsterer J．Life-threatening epistaxis and red blood cell polyagglutination under dabigatran[J]．Blood Coagul Fibrinolysis，2014，25(4): 384-386.
|
| [25] |
Wen L, Liu D, Zheng Y，et al.A one-step chemoenzymatic labeling strategy for probing sialylated thomsen-friedenreich antigen[J]．ACS Cent Sci，2018，4(4): 451-457.
|
| [26] |
Heublein S, Egger M, Zhu J，et al.Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer[J]．Breast Cancer Res Treat，2020，179(3): 643-652.
|
| [27] |
Santarsia S, Grosso AS, Trovão F，et al.Molecular recognition of a Thomsen-Friedenreich antigen mimetic targeting human galectin-3[J]．ChemMedChem，2018，13(19): 2030-2036.
|
| [28] |
黄园园，刘亚楠，于世鹏．CD4+T淋巴细胞相关细胞因子与桥本甲状腺炎发病机制的研究进展[J/CD]．中华诊断学电子杂志，2020，7(3): 214-216.
|
| [29] |
Beck ML.Red blood cell polyagglutination: clinical aspects[J]．Semin Hematol，2000，37(2): 186-196.
|
| [30] |
De Leo D, Antonello O. A case of polyagglutination[J]. Z Rechtsmed，1983，90(2): 147-152.
|
| [31] |
Xu F, Wang D, Cui J，et al.Demethylation of the cosmc promoter alleviatesthe progression of breast cancer through downregulation of the Tn and sialyl-Tn antigens[J]. Cancer Manag Res，2020(12): 1017-1027.
|
| [32] |
Kaczmarek R, Mikolajewicz K, Szymczak K，et al.Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase[J]．Glycoconj J，2016，33(6): 963-973.
|